<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> stimulates increased activity of <z:chebi fb="0" ids="51349">polyamine</z:chebi> oxidase, a ubiquitous enzyme that catabolizes <z:chebi fb="0" ids="51349">polyamines</z:chebi> to produce <z:chebi fb="0" ids="18090">3-aminopropanal</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="18090">3-Aminopropanal</z:chebi> is a reactive <z:chebi fb="1" ids="17478">aldehyde</z:chebi> that mediates progressive neuronal <z:mp ids='MP_0001651'>necrosis</z:mp> and glial <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Here we report that increased levels of <z:chebi fb="0" ids="18090">3-aminopropanal</z:chebi>-modified protein levels in humans after aneurysmal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> correlate with the degree of cerebral injury as measured by admission Hunt/Hess grade </plain></SENT>
<SENT sid="3" pm="."><plain>In vitro screening of clinically approved drugs reveals that N-2-mercaptopropionyl glycine (N-2-MPG), an agent clinically approved for prevention of <z:hpo ids='HP_0000787'>renal stones</z:hpo> in patients with cysteinuria, significantly inhibits the cytotoxicity of <z:chebi fb="0" ids="18090">3-aminopropanal</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>N-2-MPG reacts with <z:chebi fb="0" ids="18090">3-aminopropanal</z:chebi> to yield a nontoxic thioacetal adduct, as confirmed by electrospray ionization mass spectroscopy </plain></SENT>
<SENT sid="5" pm="."><plain>Administration of N-2-MPG in clinically relevant doses to rats significantly reduces cerebral <z:chebi fb="0" ids="18090">3-aminopropanal</z:chebi>-modified protein immunoreactivity and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in a standardized model of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, even when the agent is administered after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These results implicate <z:chebi fb="0" ids="18090">3-aminopropanal</z:chebi> as a therapeutic target for <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>